|本期目录/Table of Contents|

[1]宋艳玲.阿奇霉素联合孟鲁司特钠治疗支原体肺炎患儿的效果研究[J].传染病信息,2019,02:145-147.
 SONG Yan-ling.Efficacy of azithromycin combined with montelukast sodium in treatment of mycoplasma pneumonia in children[J].Infectious Disease Information,2019,02:145-147.
点击复制

阿奇霉素联合孟鲁司特钠治疗支原体肺炎患儿的效果研究(PDF)

《传染病信息》[ISSN:1007-8134/CN:11-3886/R]

期数:
2019年02期
页码:
145-147
栏目:
论 著
出版日期:
2019-05-15

文章信息/Info

Title:
Efficacy of azithromycin combined with montelukast sodium in treatment of mycoplasma pneumonia in children
文章编号:
1007-8134(2019)02-0145-03
作者:
宋艳玲
726000,商洛市中心医院儿科二病区(宋艳玲)
Author(s):
SONG Yan-ling
Second Ward of Pediatrics, Shangluo Central Hospital, 726000, China
关键词:
阿奇霉素孟鲁司特钠支原体肺炎儿童
Keywords:
azithromycin montelukast sodium mycoplasma pneumonia children
分类号:
R378
DOI:
10.3969/j.issn.1007-8134.2019.02.012
文献标识码:
A
摘要:
目的 分析阿奇霉素联合孟鲁司特钠治疗支原体肺炎患儿的疗效。方法 选取我院于2016 年3 月—2018 年 3 月收治的160 例支原体肺炎患儿作为研究对象,随机分为2 组。对照组采用阿奇霉素治疗,观察组采用阿奇霉素联合孟 鲁司特钠治疗,分析2 组患儿治疗后的临床疗效。结果 观察组啰音消失时间、咳嗽消失时间、喘憋消失时间、平均退热 时间均短于对照组(P 均< 0.05)。治疗后观察组降钙素原、CRP 下降幅度均大于对照组(P 均< 0.05)。2 组患儿不良反 应情况差异无统计学意义(P > 0.05)。结论 阿奇霉素联合孟鲁司特钠治疗支原体肺炎,与单用阿奇霉素比较能够快速缓 解患儿临床症状和体征,未增加不良反应。  
Abstract:
Objective To analyze the efficacy of azithromycin combined with montelukast sodium in the treatment of mycoplasma pneumonia in children. Methods From March 2016 to March 2018, 160 children of mycoplasma pneumonia in our hospital were randomly divided into 2 groups. The patients in the control group were treated with azithromycin and the patients in the observation group were treated with azithromycin combined with montelukast sodium. Results In the observation group, the pulmonary rales disappearance time, cough disappearance time, asthma disappearance time and average fever clearance time were shorter than those in the control group, and the difference was statistically significant (P < 0.05). The decrease of procalcitonin and CRP levels in the observation group was more obvious than that in the control group after treatment (P < 0.05). There was no statistical significance in the incidence of adverse reactions between 2 groups (P > 0.05). Conclusions Azithromycin combined with montelukast sodium in the treatment of mycoplasma pneumonia in children can quickly relieve the clinical symptoms and signs of children compared with azithromycin alone, without increasing adverse reactions. 

参考文献/References


[1] Benzaquen M, Lehowitz D, Belenotti P, et al. Acute pancreatitis and pneumonia due to Mycoplasma pneumoniae: a case report[J]. BMC Res Notes, 2016, 9:397.
[2] 郭敏,李奎臣,刘建云,等. 肺炎支原体肺炎患儿不同疗 程阿奇霉素的应用效果研究[J]. 中华医院感染学杂志, 2016,26(8):1882-1883,1889.
[3] 梁燕珍. 阿奇霉素联合孟鲁司特钠对肺炎支原体肺炎儿童 疗效及肺功能的影响[J]. 黑龙江医药,2017,30(6):1265- 1266.
[4] 黎明,杨威. 孟鲁司特治疗对支气管哮喘患者肺功能及Th1、 Treg 平衡的调节作用[J].临床和实验医学杂志,2017, 16(2):187-190.
[5] 胡亚美,江载芳. 诸福棠实用儿科学[M]. 7 版. 北京: 人民 卫生出版社,2005:154.
[6] 张喆,杜青,施红波,等. 阿奇霉素联合甘草锌治疗支原体 肺炎患儿疗效的研究[J]. 中华医院感染学杂志,2016, 26(12):2848-2850.
[7] Chaudhr R,Ghosh A,Chandolia A. Pathogenesis of Mycoplasma pneumoniae: an update[J]. Indian J Med Microbiol, 2016, 34(1):7-16.
[8] 周博,侯利,陈剑,等. 阿奇霉素联合孟鲁司特钠对肺炎支 原体肺炎患儿免疫功能及肺功能的影响[J]. 医药导报, 2018,37(9):1071-1075.
[9] 夏玉平,方圆. 孟鲁司特钠联合阿奇霉素对支原体肺炎儿童 免疫功能及肺功能的影响[J]. 海南医学院学报,2016, 22(18):2115-2117.
[10] 董嘉德,黄昌靖. 人工虫草制剂对支原体肺炎患儿血清降钙 素原、CRP 及IL-17 水平的影响[J]. 中国生化药物杂志, 2016,36(3):99-101.

备注/Memo

备注/Memo:
-
更新日期/Last Update: 2019-05-15